A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer
Clinical trial NCT06362096 · UNKNOWN
Trial details
- NCT number
- NCT06362096
- Sponsor
- Huihua Xiong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2025-05-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.